Evidence map›Paper›PMID 30406327›Full record

ArticleInternational journal of hematology2019

Correction to: A phase II study of lenalidomide consolidation and maintenance therapy after autologous PBSCT in patients with multiple myeloma.

Shin-Ichi Fuchida, Kazutaka Sunami, Morio Matsumoto, Hirokazu Okumura, Tohru Murayama, Toshihiro Miyamoto, Eichi Otsuka, Naohito Fujishima, Tohru Izumi, Shigehisa Tamaki and 6 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in International journal of hematology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Shin-Ichi FuchidaDepartment of Hematology, Japan Community Health care Organization Kyoto Kuramaguchi Medical Center, 27 Shimofusa-cho, Kita-ku, Kyoto, Kyoto, 603-8151, Japan. sfuch0614@gaia.eonet.ne.jp.
Kazutaka SunamiNational Hospital Organization Okayama Medical Center, Okayama, Japan.
Morio MatsumotoNational Hospital Organization Nishigunma National Hospital, Shibukawa, Japan.
Hirokazu OkumuraToyama Prefectural Central Hospital, Toyama, Japan.
Tohru MurayamaHyogo Cancer Center, Akashi, Japan.
Toshihiro MiyamotoKyushu University Hospital, Fukuoka, Japan.
Eichi OtsukaOita Prefectural Hospital, Oita, Japan.
Naohito FujishimaAkita University Hospital, Akita, Japan.
Tohru IzumiTochigi Cancer Center, Utsunomiya, Japan.
Shigehisa TamakiIse Red Cross Hospital, Ise, Japan.
Yasushi HiramatsuJapanese Red Cross Society Himeji Hospital, Himeji, Japan.
Yoshiaki KurodaHiroshima University Hospital, Hiroshima, Japan.
Chihiro ShimazakiDepartment of Hematology, Japan Community Health care Organization Kyoto Kuramaguchi Medical Center, 27 Shimofusa-cho, Kita-ku, Kyoto, Kyoto, 603-8151, Japan.
Koichi AkashiKyushu University Hospital, Fukuoka, Japan.
Mine HaradaKaratsu Higashimatsuura Medical Association, Karatsu, Japan.
Japan Study Group for Cell Therapy and Transplantation (JSCT)

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the original publication of this article, "Conflict of interest" was published incorrectly. The corrected "Conflict of interest" is given below for your reading.

Identifiers

PMID30406327

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.